| Jennifer Robinson » |
Promoting Temporomandibular Joint Fibrochondrogenesis through the use of an Estrogen Receptor Alpha Selective Agonist to Treat Osteoarthritis |
Howard Hughes Medical Institute |
$50,000 |
09/01/2020 |
| Rick Dobrowsky » |
A Novel Pharmacologic Approach to Treat CMT1X |
National Institutes of Health |
$387,165 |
09/15/2020 |
| Anthony Fehr » |
Determining mechanisms of innate immune modulation by ADP-ribosylation |
National Institutes of Health |
$1,680,080 |
09/15/2020 |
| David Davido » |
Role of CDKs in HSV-1 ICP0 functions |
University of Kansas Medical Center Research Institute |
$25,000 |
10/01/2020 |
| Brandon DeKosky » |
Bridge Proposal:Droplet-based single B and T cell receptor screening for multi-parameter adaptive immune monitoring |
University of Kansas Medical Center Research Institute |
$40,000 |
10/01/2020 |
| Teruna Siahaan » |
Non-Invasive Brain Delivery Clearance and Efficacy of Therapeutic Antibodies in Mice |
PHRMA Foundation |
$25,000 |
01/01/2021 |
| Yoshiaki Azuma » |
Targeting mitotic function of the PICH (Polo-like kinase interacting checkpoint helicase) for novel therapeutics of TNBC |
University of Kansas Medical Center Research Institute |
$35,000 |
01/01/2021 |
| Liang Xu » |
Drug the Undruggable Musashi Oncoprotein by Fragment-based Drug Discovery |
University of Kansas Medical Center Research Institute |
$35,000 |
01/01/2021 |
| Laird Forrest » |
Mitochondria targeting for Alzheimer’s Disease |
National Institutes of Health |
$416,625 |
02/01/2021 |
| Zarco Boskovic » |
Benzoylation of proteins with synthetic compounds and its prevention with polyamines |
University of New Mexico |
$7,500 |
02/22/2021 |
| Zarco Boskovic » |
Benzoylation of proteins with synthetic compounds and its prevention with polyamines |
University of New Mexico |
$25,000 |
03/01/2021 |
| Brandon DeKosky » |
Improved T Cell Receptor Screening Award Organization for Rapid Personalized Cancer Treatments |
University of Kansas Medical Center Research Institute |
$25,000 |
03/01/2021 |
| Berl Oakley » |
Resistance-gene-guided genome mining for novel antifungal compounds |
National Institutes of Health |
$437,201 |
03/08/2021 |
